Get the Stockscreener App
9.32
2.10%
-0.20
After Hours:
9.34
0.02
+0.21%
Compass Pathways Plc Adr stock is traded at $9.32, with a volume of 2.56M.
It is down -2.10% in the last 24 hours and up +60.97% over the past month.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
See More
Previous Close:
$9.52
Open:
$9.5
24h Volume:
2.56M
Relative Volume:
0.62
Market Cap:
$1.26B
Revenue:
-
Net Income/Loss:
$-287.41M
P/E Ratio:
-3.0515
EPS:
-3.0542
Net Cash Flow:
$-157.61M
1W Performance:
+10.43%
1M Performance:
+60.97%
6M Performance:
+69.76%
1Y Performance:
+130.69%
1-Day Range:
$9.12
$9.571
1-Week Range:
$8.22
$9.625
52-Week Range:
$2.25
$10.21
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc Adr
Sector
Industry
Phone
1-716-676-6461
Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
9.32 | 1.28B | 0 | -287.41M | -157.61M | -3.0542 |
HCA
Hca Healthcare Inc
|
428.79 | 94.77B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
186.91 | 15.97B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
20.19 | 12.38B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.16 | 10.58B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
157.04 | 10.16B | 13.64B | 1.05B | 1.31B | 9.555 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | B. Riley Securities | Buy |
| Dec-10-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-23-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-27-25 | Initiated | Stifel | Buy |
| Jul-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Apr-01-24 | Initiated | Morgan Stanley | Overweight |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Nov-21-22 | Resumed | Berenberg | Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Oct-29-21 | Initiated | Oppenheimer | Outperform |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
| May-11-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-01-21 | Initiated | ROTH Capital | Buy |
| Oct-14-20 | Initiated | H.C. Wainwright | Buy |
| Oct-13-20 | Initiated | Berenberg | Buy |
| Oct-13-20 | Initiated | Canaccord Genuity | Buy |
| Oct-13-20 | Initiated | Cowen | Outperform |
| Oct-13-20 | Initiated | Evercore ISI | Outperform |
View All
Compass Pathways Plc Adr Stock (CMPS) Latest News
What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN
symbol__ Stock Quote Price and Forecast - CNN
These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat
CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill
BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart.com
Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance
These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com
Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN
This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa
Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat
Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa
FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India
FDA grants priority voucher to Compass for psilocybin treatment - Investing.com
Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What's Going On With Enveric Biosciences Stock On Friday? - Sahm
Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat
How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN
Compass Pathways (NASDAQ:CMPS) Shares Down 7.3%Should You Sell? - MarketBeat
What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now? - Yahoo Finance
How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136% - sharewise.com
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On? - Sahm
Compass Pathways partners with Osmind on psychedelic treatment delivery By Investing.com - Investing.com South Africa
Compass Pathways partners with Osmind on psychedelic treatment delivery - Investing.com
Compass Pathways (NASDAQ:CMPS) Hits New 1-Year HighHere's What Happened - MarketBeat
Company News for Apr 21, 2026 - Yahoo Finance UK
This 4/20, Wall Street Is Betting on More Than Marijuana - MarketBeat
Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? - Barchart
Compass Pathways (NASDAQ:CMPS) Shares Gap UpHere's Why - MarketBeat
Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga
Investors Purchase Large Volume of Call Options on Compass Pathways (NASDAQ:CMPS) - MarketBeat
Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' - Sahm
Compass Pathways : Notice of 2026 AGM - marketscreener.com
Short Interest in Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Rises By 39.5% - MarketBeat
Board-backed 2026 AGM agenda set at Compass Pathways (NASDAQ: CMPS) - Stock Titan
Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling NDA and 2026 Launch Readiness - Yahoo Finance
Compass Pathways opens grant program for psilocybin training - Investing.com
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
COMPASS Pathways stock: Why psychedelic therapy potential draws investors now - AD HOC NEWS
Compass Pathways Plc Adr Stock (CMPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):